Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 841860 of 20,252 grants

Active NON-SBIR/STTR RPGS
NRF2 suppression of inflammatory signaling and its role in tumor progression
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2029

Project Summary/Abstract Tumor metastasis is responsible for the vast majority of deaths from epithelial cancers, including breast cancer. Understanding how cancer cells spread to...

$5.97M
USD
Active NON-SBIR/STTR RPGS
Alternative splicing and isoform expression as mediators for the genetic etiology of breast cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2026

ABSTRACT A drawback of genome-wide association studies (GWAS) for breast cancer risk and related phenotypes is their limited insights into genotype-to-phenotype mechanisms for iden...

$4.07M
USD
Active NON-SBIR/STTR RPGS
The resurgence of antibody-drug conjugates via PMPC-polymer engineering
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2029

Project Summary: We have patented a novel polymer-based in vivo-delivery platform for therapeutic antibodies using a super- hydrophilic polymer, poly 2-methacryloyloxyethyl phospho...

$5.85M
USD
Active NON-SBIR/STTR RPGS
Harnessing the potential of pharmacological small molecules to amplify VSV-based oncolytic viral therapy
NATIONAL CANCER INSTITUTE Southern University A&M Col Baton Rouge United States 2024 – 2027

Abstract Malignant cutaneous melanoma is the most lethal form of all skin cancers causing 10,000 deaths annually in the United States and 200,000 globally and remains a major oncol...

$4.09M
USD
Active NON-SBIR/STTR RPGS
Immunosurveillance of breast glands with oncogenic germline mutations
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2026

Project Summary/Abstract The overarching goal of the proposed research is to realize the immune system's potential for breast cancer prevention in BRCA mutation carriers. Immu...

$7.98M
USD
Active NON-SBIR/STTR RPGS
Implementation of Comprehensive Survivorship Care Intervention Across FQHC-Based Primary Care Practices
NATIONAL CANCER INSTITUTE University of Miami Coral Gables United States 2024 – 2029

Implementation of a Comprehensive Survivorship Care Intervention Across FQHC-Based Primary Care Practices PROJECT SUMMARY Cancer survivorship challenges adversely contribute to can...

$8.61M
USD
Completed OTHER RESEARCH-RELATED
2024 Chromatin Structure and Function Gordon Research Conference and Gordon Research Seminar
NATIONAL CANCER INSTITUTE Gordon Research Conferences United States 2024 – 2024

Project Summary This proposal requests support for the 2024 GRC and GRS meeting on Chromatin Structure & Function (focus on “Chromatin's Impact on Genome Function Across S...

$150K
USD
Active NON-SBIR/STTR RPGS
Engineering mRNA encapsulated extracellular vesicles for in vivo chimeric antigen receptor macrophage therapy for glioblastoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY Glioblastoma (GBM) is the most common and lethal primary central nervous system cancer in adults, where treatments are ineffective and often debilitating. Unlike ma...

$6.46M
USD
Active NON-SBIR/STTR RPGS
Statistical Methods for Identification and Evaluation of Predictive Biomarkers in Cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2024 – 2026

Project Summary Relapsed/refractory cancer is a principal cause of cancer-related death. Targeted therapies, which represent a new generation of cancer therapies, have advanced the...

$3.89M
USD
Active NON-SBIR/STTR RPGS
Development of a PET CCR2 Imaging Agent to Profile PDAC Microenvironment
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2026

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer. PDAC is the 4th leading cause of cancer related death with a 5-year survival rate

$4.02M
USD
Active NON-SBIR/STTR RPGS
Integration of CSF Proteogenomics in the Diagnosis and Management of Diffuse Gliomas
NATIONAL CANCER INSTITUTE Pennsylvania State University Hershey Me... United States 2024 – 2029

Project Summary Diffuse gliomas are the most common primary malignant adult brain tumor. Lower grade gliomas (Grade 2) inevitably become malignant, and prognosis is fatal. Key clin...

$6.39M
USD
Active NON-SBIR/STTR RPGS
Deciphering mechanisms of transcriptional repression which drive midline glioma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2029

PROJECT ABSTRACT: Diffuse midline glioma (DMG) is a universally lethal form of brain cancer that affects both children and adults, with most patients passing away within 1-year of...

$4.75M
USD
Active NON-SBIR/STTR RPGS
Epigenetic and metabolic bottlenecks of tumorigenesis
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2029

Recurrent metastasis is the leading cause of breast cancer mortality. Dormancy is a critical, but poorly understood, step in the tumorigenic process where breast cancer cells can r...

$6.4M
USD
Active OTHER RESEARCH-RELATED
Cancer Undergraduate Research Education Program
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

ABSTRACT Cancer disproportionately affects Black Americans and other economically disadvantaged groups, yet these individuals are underrepresented in cancer research. The Cancer Un...

$2.68M
USD
Active NON-SBIR/STTR RPGS
IAP inhibition as a therapeutic strategy to target therapy-resistant leukemia initiating cells
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

Acute myeloid leukemia (AML) is a devastating malignancy with dismal outcomes for patients, particularly in the elderly where most cases occur. The recent approval of the BCL2 inhi...

$3.88M
USD
Active NON-SBIR/STTR RPGS
Using real-time data capture to examine implicit attitudes as mediators of physical activity adherence in interventions
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2026

PROJECT SUMMARY Approximately 42% of new cancer cases in the U.S. are viewed as potentially avoidable, including 15% caused by excess body weight and physical inactivity. However,...

$1.66M
USD
Active NON-SBIR/STTR RPGS
Employing quantitative image analysis based on deep learning to improve treatment efficacy in image-guided renal tumor ablation
NATIONAL CANCER INSTITUTE Brown University United States 2024 – 2026

Image-guided thermal ablation (IGTA) is a minimally invasive, low cost, and accessible cancer treatment for patients including those who are too ill to be candidates for surgery or...

$1.65M
USD
Active NON-SBIR/STTR RPGS
Tumor stem cell initiated mitochondrial transfer
NATIONAL CANCER INSTITUTE Texas Tech University United States 2024 – 2026

Project Summary/Abstract Cancer is a metabolically heterogeneous disease. At the core of most metabolic pathways, mitochondria play central roles in cancer cell proliferation, migr...

$1.62M
USD
Active NON-SBIR/STTR RPGS
Peptide multimer for early detection of hepatocellular carcinoma
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

The incidence of hepatocellular carcinoma (HCC) is rising rapidly worldwide. In the U.S., this cancer is growing at a rate faster than that of any other cancer. New biomarkers spec...

$4.22M
USD
Active NON-SBIR/STTR RPGS
Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2024 – 2029

PROJECT SUMMARY While immunotherapies have proved compelling efficacy against other leukemias, their application for acute myeloid leukemia (AML) is still hampered by the absence o...

$7.8M
USD